Ultimovacs Announces Acceptance of Publication in ‘Frontiers in Immunology’ Featuring Positive Results From Phase I Trial Evaluating UV1 in Non-Small Cell Lung Cancer
Biospace,
Nov. 2, 2020 10:27 UTC OSLO, Norway--( BUSINESS WIRE )-- Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced the…